Michael R Hayden insider trades

Open-market stock purchases and sales by Michael R Hayden, Director at AbCellera Biologics Inc, from SEC Form 4 filings since Nov 4, 2014.

Track record: 55% of 11 scored buys are up 5% or more since purchase, averaging +24%.

Recent trades

DateStockTradeValue
Aug 24, 2026ABCL AbCellera Biologics IncBought$570K
Aug 12, 2026ABCL AbCellera Biologics IncBought$481K
Aug 11, 2026ABCL AbCellera Biologics IncSold (not open market)—
Jul 31, 2026IONS Ionis Pharmaceuticals IncBought$258K
Jul 30, 2026IONS Ionis Pharmaceuticals IncBought$801K
Jul 1, 2026IONS Ionis Pharmaceuticals IncBought (not open market)—
Jul 1, 2026IONS Ionis Pharmaceuticals IncBought (not open market)—
Jun 11, 2026ABCL AbCellera Biologics IncBought (not open market)—
Oct 30, 2025ETNB 89bio, IncSold (not open market)—
Oct 30, 2025ETNB 89bio, IncSold (not open market)—
Oct 30, 2025ETNB 89bio, IncSold (not open market)—
Oct 30, 2025ETNB 89bio, IncSold (not open market)—
Oct 30, 2025ETNB 89bio, IncSold (not open market)—
Oct 30, 2025ETNB 89bio, IncSold (not open market)—
Oct 30, 2025ETNB 89bio, IncSold (not open market)—
Oct 30, 2025ETNB 89bio, IncSold (not open market)—
Oct 30, 2025ETNB 89bio, IncSold (not open market)—
Oct 30, 2025ETNB 89bio, IncSold (not open market)—
Oct 30, 2025ETNB 89bio, IncSold (not open market)—
Oct 30, 2025ETNB 89bio, IncSold (not open market)—

Companies traded

  • ABCL AbCellera Biologics Inc: 5 buys, 1 sale, last Aug 24, 2026
  • IONS Ionis Pharmaceuticals Inc: 4 buys, last Jul 31, 2026
  • ETNB 89bio, Inc: 5 buys, last Oct 30, 2025
  • XENE Xenon Pharmaceuticals Inc: 1 buy, last Jun 3, 2021
  • AUPH Aurinia Pharmaceuticals Inc: other filings, last Jan 29, 2021

Get free alerts when Michael R Hayden files a new trade →